While Prognostic, BCR May Not Be a Strong Surrogate End Point for Prostate Cancer Survival
August 31st 2023Measuring biochemical recurrence (BCR) as a surrogate marker produces unreliable results as a primary end point for overall survival of patients with localized prostate cancer, a study found.
Read More
Combining Surgery and Biologic Therapy Improves Outcomes in Patients With CRSwNP
August 26th 2023Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy alone
Read More
Study Validates PSA-Based Recurrence Definitions for Prostate Cancer Prognostication
August 19th 2023Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment failure compared with other PSA-based definitions.
Read More
Free Myeloperoxidase Levels Show Promise for Predicting Risk of Cardiovascular, All-Cause Mortality
August 12th 2023New research suggests that measuring the inflammatory marker myeloperoxidase (MPO) may be an effective strategy for the prediction of patients' risk of mortality in a myriad of cardiac—and potentially non-cardiac—diseases.
Read More
Standard Uptake Value Index May Aid in Diagnosis of Polymyalgia Rheumatica
August 8th 2023Polymyalgia rheumatica (PMR) is an inflammatory disease often misdiagnosed as certain cancers, among other diseases. Researchers have recently made progress to better diagnose PMR using a standard uptake value index based on fluorodeoxyglucose with positron-emission tomography/computed tomography.
Read More
Nirmatrelvir-Ritonavir Reduces Risk of COVID-19 Hospitalization, Death, Study Finds
August 4th 2023The body of research on nirmatrelvir-ritonavir demonstrates a plethora of benefits in the treatment of COVID-19, and authors of a recent study identified more advantages to administering the treatment to patients with COVID-19.
Read More
Study Finds Link Between Baseline Uric Acid Levels and Prostate Cancer Prognosis
July 31st 2023Researchers linking uric acid (UA) levels to the aggressiveness and progression of prostate cancer believe these findings can be used to study UA influence on prostate cancer–related mortality risk.
Read More
Overall Survival in Advanced NSCLC Unaffected by Immunotherapy Duration Beyond 2 Years
July 29th 2023Researchers seeking answers regarding the most beneficial duration of immune checkpoint inhibitor–based therapy for non–small cell lung cancer (NSCLC) found no significant impact of indefinite-duration treatment on patient survival.
Read More
After the COVID-19 vaccine was released, disparities in COVID-19 incidence shrunk. However, although efforts were made to increase access to the COVID-19 vaccine in low-income areas, discrepancies in overall vaccination coverage persisted between higher- and lower-income communities.
Read More
Perceived Necessity vs Implementation of Psychological Support for Patients With RA in Japan
July 22nd 2023Patient-centered care (PCC) is a major part of a patient’s daily life that addresses their psychological needs, among other needs and preferences. Quality PCC has been recognized as important in clinical practice; however, implementation rates remain comparatively low.
Read More